Accessibility StatementSkip Navigation On this news, Molina's stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partn ...

Core Viewpoint - Molina Healthcare's stock plummeted over 20% following a significant earnings miss for Q3, attributed to rising medical expenses and a lowered guidance for Q4 [1][2]. Financial Performance - Molina's adjusted EPS for Q3 was $1.84, missing analyst expectations of $3.89 by more than 50% [2]. - The company projects Q4 adjusted earnings of $0.35, significantly below analysts' expectations of $2.42 [2]. Medical Care Ratio (MCR) - Molina's consolidated MCR for Q3 was 92.6%, up from 89.2% in the same quarter last year, indicating increased medical expenses impacting profitability [4]. - A 92.6% MCR means the company retained only 7.4 cents per dollar of premium revenue after covering medical expenses [5]. - The MCR for ACA plans was particularly high at 95.6%, exceeding both analyst predictions of 86% and Molina's own 73% from the previous year [6]. Industry Context - The MCR is a critical metric for healthcare providers, reflecting the balance between premium revenue and medical expenses [3]. - Rising medical costs and the structure of ACA plans have posed significant challenges for Molina, affecting its financial stability [5][6].

Economic Impact - The US government shutdown is in its fourth week, affecting market sentiment and delaying key economic reports, including unemployment claims and the September payroll report [1] - Bloomberg Economics estimates that 640,000 federal workers will be furloughed, potentially increasing jobless claims and raising the unemployment rate to 4.7% [1] Trade Relations - Markets are focused on US-China trade talks, with President Trump threatening to increase tariffs on Chinese goods if no deal is reached by November 1 [2] Sanctions - The Trump administration has announced sanctions on Rosneft PJSC and Lukoil PJSC, Russia's largest oil producers, due to insufficient commitment to peace in Ukraine, which may restrict their access to international financial systems [3] Company Performance - Molina Healthcare's stock has dropped over 20% after it cut its full-year adjusted EPS forecast from $19.00 to $14.00, significantly below the consensus of $18.65 [4][15] - International Business Machines (IBM) is down more than 3% after reporting a 14% increase in its Q3 hybrid cloud unit, which was below the expected 16% [4][19] - Tesla's stock is down more than 3% after reporting Q3 EPS of 50 cents, below the consensus of 54 cents [4][19] - Las Vegas Sands reported Q3 net revenue of $3.33 billion, exceeding the consensus of $3.04 billion, leading to a stock increase of over 12% [16] - Dow Inc. reported Q3 adjusted operating Ebitda of $868 million, surpassing the consensus of $759.7 million, resulting in an increase of over 9% in its stock [16] Market Trends - The S&P 500 Index is up 0.38%, with the Dow Jones up 0.12% and the Nasdaq 100 up 0.61% [7] - The Q3 earnings season shows rising corporate earnings expectations, with 85% of S&P 500 companies that have reported so far beating forecasts, indicating a strong quarter [8] - Q3 profits are expected to rise by 7.2% year-over-year, the smallest increase in two years, while sales growth is projected to slow to 5.9% year-over-year [8] Interest Rates - The markets are pricing in a 99% chance of a 25 basis point rate cut at the next FOMC meeting on October 28-29 [9] - The 10-year T-note yield is up 3.2 basis points to 3.982%, influenced by inflation concerns due to a 5% surge in WTI crude oil prices [10]

Healthcare Sector - Molina Healthcare's stock has dropped over 20% following a disappointing earnings report and guidance cut, marking the third reduction this year [1][2][3] - The company's earnings per share (EPS) was reported at $1.84, significantly below the expected $4, while revenue was $11.48 billion, which beat estimates but was overshadowed by the EPS miss [2][3] - Molina attributed the guidance cut to unprecedented medical costs, particularly in its marketplace business, which has seen higher usage of medical services and sicker patient pools [3][4] - The medical care ratio for Molina rose to 92.6%, indicating reduced profit margins per premium dollar [4] Airline Sector - American Airlines reported a smaller-than-expected loss of $0.17 per share, with revenue of $13.7 billion, both better than anticipated [6][7] - The airline is projecting a profit for 2025 and expects earnings between $0.45 and $0.75 per share for the fourth quarter, exceeding analyst estimates [6][7] - Domestic demand, particularly for business and premium travel, remains strong, with capacity expected to grow by 3-5% in the fourth quarter [8][9] - Southwest Airlines posted a surprise profit of $0.11 per share and nearly $7 billion in revenue, indicating strong demand heading into the holiday season [11][12] - Southwest is making changes to its seating policy and introducing fees for bags and seat upgrades, which are already contributing to increased sales [13][14] Casino Sector - Las Vegas Sands and other casino stocks are experiencing positive analyst sentiment, with shares up approximately 9.5% [15]

Economic Impact - The US government shutdown is in its fourth week, affecting market sentiment and delaying key economic reports, including unemployment claims and the September payroll report [1] - Bloomberg Economics estimates that 640,000 federal workers will be furloughed, potentially increasing jobless claims and raising the unemployment rate to 4.7% [1] Trade Relations - Markets are focused on US-China trade talks, with President Trump threatening to increase tariffs on Chinese goods if no deal is reached by November 1 [2] Sanctions - The Trump administration has imposed sanctions on Rosneft PJSC and Lukoil PJSC, Russia's largest oil producers, due to insufficient commitment to peace in Ukraine, which may restrict their international business operations [3] Company Performance - Molina Healthcare's stock has dropped over 20% after revising its full-year adjusted EPS forecast down to $14.00 from $19.00, below the consensus of $18.65 [4][12] - International Business Machines (IBM) is down more than 4% after reporting a smaller-than-expected increase in its Q3 hybrid cloud unit [4][15] - Tesla's stock is down more than 3% after reporting Q3 EPS below consensus [4][15] Market Movements - Stock indexes are rising, led by energy producers, following a more than 5% increase in WTI crude oil prices due to sanctions on Russian oil companies [5] - Dow Inc. is up more than 11% after reporting Q3 adjusted operating EBITDA of $868 million, exceeding the consensus of $759.7 million [5][13] - Honeywell International's stock is up more than 5% after reporting Q3 sales of $10.41 billion, surpassing the consensus of $10.15 billion [5][14] Earnings Season - The Q3 earnings season is ongoing, with 85% of S&P 500 companies that have reported so far beating forecasts, indicating a strong quarter since 2021 [5] - Q3 profits are expected to rise by 7.2% year-over-year, the smallest increase in two years, while sales growth is projected to slow to 5.9% year-over-year [5] Interest Rates - Markets are anticipating a 99% chance of a 25 basis point rate cut at the next FOMC meeting on October 28-29 [6] - T-notes are under pressure due to inflation concerns, with a 5% surge in WTI crude oil prices raising inflation expectations [7][8]

Core Insights - UnitedHealth Group's stock experienced a 31% increase over three months, influenced by a 3.1% rise in revenue and a 35% increase in P/E multiple, despite a 6.6% decrease in net margin [2][3] Financial Performance - Q2 2025 adjusted EPS was $4.08, which fell short of expectations, leading to a downward adjustment of the 2025 EPS forecast to at least $16.00 [7] - A quarterly dividend of $2.21 per share was paid on September 23, 2025, which contributed to enhancing investor confidence [7] Regulatory and Market Factors - The Department of Justice is investigating Medicare billing practices, while senators are looking into nursing home operations, indicating regulatory scrutiny [7] - Warren Buffett's Berkshire Hathaway acquired over 5 million shares of UNH stock during Q2 2025, valued at approximately $1.6 billion, which boosted investor confidence [7] Technological Investments - The launch of Optum Real, an AI system aimed at optimizing claims processing, is expected to generate cost savings and new revenue streams [7]

Financial Data and Key Metrics Changes - The company reported adjusted EPS of $1.84 on $10.8 billion of premium revenue, which was below expectations [6][17] - The consolidated MCR for the quarter was 92.6%, reflecting a challenging medical cost environment [6][17] - Year-to-date, the consolidated MCR stands at 90.8% with an adjusted pre-tax margin of 2.7% [6] Business Line Data and Key Metrics Changes - In Medicaid, which represents 75% of total premium revenue, the MCR was reported at 92% with an adjusted pre-tax margin of 2.6% [7][17] - The Medicare segment reported a third quarter MCR of 93.6%, with higher utilization in high-acuity populations [7][17] - The Marketplace segment had a significantly higher MCR of 95.6%, driven by elevated utilization [7][17] Market Data and Key Metrics Changes - The company anticipates full-year premium revenue to increase to approximately $42.5 billion [8][22] - The adjusted EPS guidance for 2025 has been revised down to approximately $14 per share, reflecting a consolidated MCR of 91.3% [8][22] - The Medicaid MCR is expected to be 91.5% for the full year, which is above the high end of the long-term target range [9][22] Company Strategy and Development Direction - The company aims to surpass the $50 billion premium revenue mark in the coming years, with a focus on winning RFPs and pursuing M&A opportunities [14][72] - The 2026 outlook anticipates growth in existing markets and new Medicaid contracts, despite potential revenue headwinds from Marketplace pricing strategies [12][25] - The company is strategically focused on the dual-eligible segment in Medicare, which is expected to drive profitable growth [15][66] Management Comments on Operating Environment and Future Outlook - Management acknowledged the challenging medical cost environment and the impact on earnings, particularly in the Marketplace segment [6][10] - The company remains optimistic about future Medicaid rates keeping pace with medical cost trends, citing responsiveness from state partners [40][42] - Management believes that the current high medical cost trends will eventually stabilize, allowing for a return to target margins [59][62] Other Important Information - The company has a strong capital foundation, with RBC ratios at 340% and total subsidiary capital 70% above state minimums [20] - The company repurchased approximately 2.8 million shares at a cost of $500 million, indicating confidence in long-term value [21] - The embedded earnings are estimated at $8.65 per share, with expectations for realization over time [60][62] Q&A Session Summary Question: Can you elaborate on the drivers of ACA MCR pressure in the quarter? - Management indicated that the pressure was due to increased medical cost trends across all categories, with a higher percentage of special enrollment membership contributing to the trend [32][33] Question: Are you expecting Medicaid rates to be in excess of the 7% cost trend? - Management expressed optimism that rates will at least keep pace with the trend, citing responsiveness from states and a solid baseline for rate projections [39][41] Question: How does the expiration of subsidies affect your pricing assumptions for Marketplace? - Management stated that pricing is based on the expiration of subsidies, with a focus on achieving break-even or better margins [44][45] Question: What is the outlook for Medicare performance next year? - Management noted that the Medicare business is rejuvenating, particularly with the transition of MMPs to FIDEs and HIDEs, and expects slight margin erosion but overall stability [66][67] Question: How is the M&A pipeline developing? - Management highlighted a full pipeline of actionable opportunities, particularly among smaller health plans facing operational difficulties, and emphasized disciplined capital allocation [71][72]

Key Points UnitedHealth's decision to exit 100-plus Medicare Advantage plans was a prudent move. The stock could have significant upside potential as its bottom line improves. One key wild card for UnitedHealth, though, is the ongoing U.S. Department of Justice investigation. 10 stocks we like better than UnitedHealth Group › Some might view UnitedHealth Group (NYSE: UNH) as a stock and a company in retreat. UnitedHealth's shares have plunged more than 40% below the high set in the fourth quarter ...

Molina Healthcare shares fell about 20% in premarket trading on Thursday, a day after the insurer cut its annual profit forecast for the third time this year, driven by higher medical costs across its... ...

Elevance Health, Inc. (NYSE:ELV) is one of the best long term low volatility stocks to buy right now. Elevance Health, Inc. (NYSE:ELV) reported its fiscal Q3 2025 results on October 21, announcing $50.1 billion in operating revenue for the quarter, up 12.0% compared to the same quarter last year. Diluted EPS for the quarter reached $5.32, while adjusted diluted EPS was $6.03. Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings The company reaffirmed its fiscal year 2025 benefit expense ratio and ...